Octreotide is an octapeptide that resembles natural somatostatin pharmacologically. Octreotide acetate is widely used in the treatment of some types of cancers, diarrhea, and tumors such as carcinoid, pancreatic islet cell tumors, and vasoactive intestinal peptide secreting tumors. Octreotide acetate is also used to treat acromegaly when the body produces excess of hormone, which causes enlarged feet, hands, face, and head.
Click To Continue Reading on Octreotide Market
Major driver for growth of the octreotide market is the robust pipeline of drugs in clinical trials. For instance, in 2016, Mario Negri Institute for pharmacological research completed phase 2 clinical trials of its octreotide LAR in combination with tolvaptan drug for the treatment of autosomal dominant polycystic kidney disease. This disease has an effect on the glomerular rate and total kidney and cystic volume. Octreotide is sponsored by Radbound University in Phase 3 clinical trials from 2016. This drug is under clinical trial for the treatment of angiodysplasia, vascular malformation, gastrointestinal hemorrhage, and anemia with Octreotide. Injection Octreotide, sponsored by PVS memorial hospital, is in phase 4 clinical trials since 2016.
This injection is indicated for treatment of pancreatic fistula and complications of pancreatoduodenectomy among patients with soft pancreas. Furthermore, CAM2029 is being tested, currently in phase 2, for acromegaly and neuroendocrine tumors by Camurus AB in collaboration with Novartis AG. Octreotide chloride is the active ingredient for this product. Increasing prevalence of disease. Searching for acromegaly and cancer. Octreotide drugs increasing in size. According to a survey conducted by National Institute of Health in 2015, over 4 million people suffer from acromegaly in the US
Request Sample Copy of this Business Report @ https://www.coherentmarketinsights.com/insight/request-sample/1836
Key Vendors:
Samarth Pharma Pvt Ltd., Sun Pharmaceuticals Industries Ltd., Neiss Labs Pvt. Ltd., Novartis AG, and Unique Chemical Ltd.
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through emerging market trends, technologies, and potential absolute dollar opportunities.
Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave, # 3200
Seattle, WA 98154
Tel: + 1-206-701-6702
Email: sales@coherentmarketinsights.com
Visit our news site: https://www.coherenttimes.org/